Home
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava
- Modern Science Confirms Ancient Wisdom!
- Modern Science Confirms Ancient Wisdom!
- "Natural" or "Plant-Derived" Labeling Can Mislead
- CDN: Natural Health Products Report - Update
- NPI Editorial: Are we using Best Practices?
- AHPA Update: Kava Information from the AHPA Executive Committee
- European Commission Proposes Registration Scheme for Herbal Medicine to Avoid Need for Testing
- Statement on Kava in New Zealand
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- Indena Reports 2005 Financial Results
Company reports group turnover of €170 million, up 19% over prior year, with €23,921 million pre tax profits, compared to € 8,353 million prior year.
- SunOpta Announces Agreement with Germany's Mikro-Technik to Expand Fiber Portfolio and North American Distribution
Company has entered into an exclusive licensing arrangement with Mikro-Technik GmbH & Co. KG of Burgstadt, Germany (Mikro-Technik) for the sales, marketing and distribution of Mikro-Technik's wheat and bamboo fibers, and its powdered cellulose products in North America.
- SunOpta Announces Agreement with Germany's Mikro-Technik to Expand Fiber Portfolio and North American Distribution
Company has entered into an exclusive licensing arrangement with Mikro-Technik GmbH & Co. KG of Burgstadt, Germany (Mikro-Technik) for the sales, marketing and distribution of Mikro-Technik's wheat and bamboo fibers, and its powdered cellulose products in North America.
- SunOpta Announces Agreement with Germany's Mikro-Technik to Expand Fiber Portfolio and North American Distribution
Company has entered into an exclusive licensing arrangement with Mikro-Technik GmbH & Co. KG of Burgstadt, Germany (Mikro-Technik) for the sales, marketing and distribution of Mikro-Technik's wheat and bamboo fibers, and its powdered cellulose products in North America.
- Martek Announces New Infant Formula Licensee
Company announces that South Korean infant formula market leader, Namyang Dairy Products Co., Ltd., has signed a license and supply agreement for rights to use Martek's docosahexaenoic acid (DHA) and arachidonic acid (ARA) in infant formula sold in South Korea.
- Martek Announces New Infant Formula Licensee
Company announces that South Korean infant formula market leader, Namyang Dairy Products Co., Ltd., has signed a license and supply agreement for rights to use Martek's docosahexaenoic acid (DHA) and arachidonic acid (ARA) in infant formula sold in South Korea.
- Martek Announces New Infant Formula Licensee
Company announces that South Korean infant formula market leader, Namyang Dairy Products Co., Ltd., has signed a license and supply agreement for rights to use Martek's docosahexaenoic acid (DHA) and arachidonic acid (ARA) in infant formula sold in South Korea.
- Advitech Announces Changes in Management Staff
Jean-Luc Martre, Vice-President sales and marketing, will be leaving Advitech, Christian Brouillette MSc, MBA, will become Advitech's sales and marketing director, and Kim Cantin, BSc, becomes Quality Control/Assurance Director.
- Advitech Announces Changes in Management Staff
Jean-Luc Martre, Vice-President sales and marketing, will be leaving Advitech, Christian Brouillette MSc, MBA, will become Advitech's sales and marketing director, and Kim Cantin, BSc, becomes Quality Control/Assurance Director.
- Advitech Announces Changes in Management Staff
Jean-Luc Martre, Vice-President sales and marketing, will be leaving Advitech, Christian Brouillette MSc, MBA, will become Advitech's sales and marketing director, and Kim Cantin, BSc, becomes Quality Control/Assurance Director.
- Advitech Announces Changes in Management Staff
Jean-Luc Martre, Vice-President sales and marketing, will be leaving Advitech, Christian Brouillette MSc, MBA, will become Advitech's sales and marketing director, and Kim Cantin, BSc, becomes Quality Control/Assurance Director.
- Synutra Reports Fourth Quarter and Year-end Results
Company reports Q4 sales of $30.7 million, as compared to $17.3 million for the same period in 2005, with net income of $4.2 million, compared to net income of $4.6 million from the same period in 2005.
- Synutra Reports Fourth Quarter and Year-end Results
Company reports Q4 sales of $30.7 million, as compared to $17.3 million for the same period in 2005, with net income of $4.2 million, compared to net income of $4.6 million from the same period in 2005.
- DANONE Invests in Market Leading Chinese Fruit Juice Company
Company announces that it has acquired 22.18% of the Chinese fruit beverages company China Hui Yuan Juice Holdings Co., Ltd
- DANONE Invests in Market Leading Chinese Fruit Juice Company
Company announces that it has acquired 22.18% of the Chinese fruit beverages company China Hui Yuan Juice Holdings Co., Ltd
- Bayer Pharma Signs Agreement with Vitiva
Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts.
- Bayer Pharma Signs Agreement with Vitiva
Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts.
- Bayer Pharma Signs Agreement with Vitiva
Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts.
- Bayer Pharma Signs Agreement with Vitiva
Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts.
- Bayer Pharma Signs Agreement with Vitiva
Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts.
- Bayer Pharma Signs Agreement with Vitiva
Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts.
- Health Sciences Group Appoints New CEO
Company's Board of Directors has appointed Stuart Gold as its Chief Executive Officer.
- Health Sciences Group Appoints New CEO
Company's Board of Directors has appointed Stuart Gold as its Chief Executive Officer.
- Health Sciences Group Appoints New CEO
Company's Board of Directors has appointed Stuart Gold as its Chief Executive Officer.
- Health Sciences Group Appoints New CEO
Company's Board of Directors has appointed Stuart Gold as its Chief Executive Officer.
- Lifeway Foods Reports Record Second Quarter 2006 Sales Results
Company reports sales of $6,365,147 compared to $5,072,567 during the same period a year ago.
- Lifeway Foods Reports Record Second Quarter 2006 Sales Results
Company reports sales of $6,365,147 compared to $5,072,567 during the same period a year ago.
- Huber Engineered Materials Acquires West Coast Ingredients
Huber Engineered Materials, part of J.M. Huber Corporation, today announced the acquisition of West Coast Ingredients in Modesto, Calif. Terms of the deal were not released.
- Huber Engineered Materials Acquires West Coast Ingredients
Huber Engineered Materials, part of J.M. Huber Corporation, today announced the acquisition of West Coast Ingredients in Modesto, Calif. Terms of the deal were not released.
- Natrol Elects James Peters to Its Board of Directors
Company has announced the election of James R. Peters to its Board of Directors. Mr. Peters is expected to be named Chairman of the Audit Committee.
- Natrol Elects James Peters to Its Board of Directors
Company has announced the election of James R. Peters to its Board of Directors. Mr. Peters is expected to be named Chairman of the Audit Committee.
- Natrol Elects James Peters to Its Board of Directors
Company has announced the election of James R. Peters to its Board of Directors. Mr. Peters is expected to be named Chairman of the Audit Committee.
- Natrol Elects James Peters to Its Board of Directors
Company has announced the election of James R. Peters to its Board of Directors. Mr. Peters is expected to be named Chairman of the Audit Committee.
- Natural Alternatives International, Inc. Announces Fourth Quarter Sales Results and Changes to Executive Team
Company announces net sales in excess of $33 million for the three months ended June 30, 2006, surpassing the previous quarterly net sales record set in the fourth quarter of fiscal 2005, and that John Dullea has assumed additional responsibilities as Executive Vice President of NAI and will be responsible for all sales and marketing activities of NAI. Tim Belanger, former Senior Vice President - Sales and Marketing, and Mark Zimmerman, former Vice President - Operations, are no longer with the company.
- Natural Alternatives International, Inc. Announces Fourth Quarter Sales Results and Changes to Executive Team
Company announces net sales in excess of $33 million for the three months ended June 30, 2006, surpassing the previous quarterly net sales record set in the fourth quarter of fiscal 2005, and that John Dullea has assumed additional responsibilities as Executive Vice President of NAI and will be responsible for all sales and marketing activities of NAI. Tim Belanger, former Senior Vice President - Sales and Marketing, and Mark Zimmerman, former Vice President - Operations, are no longer with the company.
- Cognis Completes Acquisition of Omega-3 Fish Oil Company
Company has completed the acquisition of Napro Pharma AS, a Norwegian manufacturer of high-quality omega-3 fish oils for the nutrition industry.
- Cognis Completes Acquisition of Omega-3 Fish Oil Company
Company has completed the acquisition of Napro Pharma AS, a Norwegian manufacturer of high-quality omega-3 fish oils for the nutrition industry.
- Cognis Completes Acquisition of Omega-3 Fish Oil Company
Company has completed the acquisition of Napro Pharma AS, a Norwegian manufacturer of high-quality omega-3 fish oils for the nutrition industry.
- Cognis Completes Acquisition of Omega-3 Fish Oil Company
Company has completed the acquisition of Napro Pharma AS, a Norwegian manufacturer of high-quality omega-3 fish oils for the nutrition industry.
- Cognis Completes Acquisition of Omega-3 Fish Oil Company
Company has completed the acquisition of Napro Pharma AS, a Norwegian manufacturer of high-quality omega-3 fish oils for the nutrition industry.
- New Patent Promotes Soy Isoflavone Benefits
The U.S. Patent Office has issued patent number 7,045,155 to Novogen, Ltd; This patent, which Acatris has exclusively licensed, protects compositions for the amelioration of human health conditions that are responsive to treatment with phyto-estrogens. The compositions comprise phytoestrogen-enriched extracts primarily from soy hypocotyls.
- New Patent Promotes Soy Isoflavone Benefits
The U.S. Patent Office has issued patent number 7,045,155 to Novogen, Ltd; This patent, which Acatris has exclusively licensed, protects compositions for the amelioration of human health conditions that are responsive to treatment with phyto-estrogens. The compositions comprise phytoestrogen-enriched extracts primarily from soy hypocotyls.
- New Patent Promotes Soy Isoflavone Benefits
The U.S. Patent Office has issued patent number 7,045,155 to Novogen, Ltd; This patent, which Acatris has exclusively licensed, protects compositions for the amelioration of human health conditions that are responsive to treatment with phyto-estrogens. The compositions comprise phytoestrogen-enriched extracts primarily from soy hypocotyls.
- Dynamic Health Products, Inc. Reports 2006 Revenue
Company reports revenues of $50.1 million, an increase of 212% over the prior year's revenues of $16.1 million, with net income applicable to common shareholders of $5.9 million compared to a net loss of $4.4 million in the prior year.
- Dynamic Health Products, Inc. Reports 2006 Revenue
Company reports revenues of $50.1 million, an increase of 212% over the prior year's revenues of $16.1 million, with net income applicable to common shareholders of $5.9 million compared to a net loss of $4.4 million in the prior year.
- Schiff Nutrition International, Inc. Announces Fiscal 2006 Fourth Quarter and Year-End Results
Company reports net sales of $45.3 million for the three months ended May 31, 2006, compared to $39.9 million for the same period in fiscal 2005, with net income of $6.2 million, or $0.23 per diluted share, versus a net loss of ($1.8) million, or ($0.07) per share, which included an after-tax loss from discontinued operations of ($5.7) million for the same period a year ago.
- Schiff Nutrition International, Inc. Announces Fiscal 2006 Fourth Quarter and Year-End Results
Company reports net sales of $45.3 million for the three months ended May 31, 2006, compared to $39.9 million for the same period in fiscal 2005, with net income of $6.2 million, or $0.23 per diluted share, versus a net loss of ($1.8) million, or ($0.07) per share, which included an after-tax loss from discontinued operations of ($5.7) million for the same period a year ago.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- Galaxy Nutritional Foods Reports FY2006 Operating Results
For the quarter, company reports a net loss of ($1,833,320), or ($0.09) per share, on net sales of approximately $8.4 million, compared with a net loss of ($2,545,790), or ($0.14) per share, and net sales of approximately $10.8 million, in the fourth quarter of the previous fiscal year.
- Galaxy Nutritional Foods Reports FY2006 Operating Results
For the quarter, company reports a net loss of ($1,833,320), or ($0.09) per share, on net sales of approximately $8.4 million, compared with a net loss of ($2,545,790), or ($0.14) per share, and net sales of approximately $10.8 million, in the fourth quarter of the previous fiscal year.
- Enzymotec and Il Dong Sign Agreement in the Korean Market
Israeli biotech company Enzymotec and Korean pharmaceuticals manufacturer Il Dong have announced signing an agreement to launch a novel supplement for CVD prevention in the Korean market.
- Enzymotec and Il Dong Sign Agreement in the Korean Market
Israeli biotech company Enzymotec and Korean pharmaceuticals manufacturer Il Dong have announced signing an agreement to launch a novel supplement for CVD prevention in the Korean market.
- NZyme Pharmaceuticals(TM), Inc. Unveils New Patent for Subtilisin NAT Applications in Decreasing Blood Viscosity
Company announces a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease
- NZyme Pharmaceuticals(TM), Inc. Unveils New Patent for Subtilisin NAT Applications in Decreasing Blood Viscosity
Company announces a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease
- NZyme Pharmaceuticals(TM), Inc. Unveils New Patent for Subtilisin NAT Applications in Decreasing Blood Viscosity
Company announces a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease
- NZyme Pharmaceuticals(TM), Inc. Unveils New Patent for Subtilisin NAT Applications in Decreasing Blood Viscosity
Company announces a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease
- NZyme Pharmaceuticals(TM), Inc. Unveils New Patent for Subtilisin NAT Applications in Decreasing Blood Viscosity
Company announces a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease
- Natural Products Association Announces Opening of China Office
Association announces the opening of a branch office in Beijing, China to better assist the U.S. companies that hope to export their products to this booming marketplace.
- Natural Products Association Announces Opening of China Office
Association announces the opening of a branch office in Beijing, China to better assist the U.S. companies that hope to export their products to this booming marketplace.
- Natural Products Association Announces Opening of China Office
Association announces the opening of a branch office in Beijing, China to better assist the U.S. companies that hope to export their products to this booming marketplace.
- Natural Products Association Announces Opening of China Office
Association announces the opening of a branch office in Beijing, China to better assist the U.S. companies that hope to export their products to this booming marketplace.
- UTEK Corporation and Gadot Biochemical Industries, Ltd. Announce Strategic Alliance
Companies announce that they have signed a strategic alliance agreement. In line with its strategic goal to develop innovative solutions for the fortification and supplement industry, Gadot is seeking new technologies to produce new health ingredients as well as to improve its current production processes.
- UTEK Corporation and Gadot Biochemical Industries, Ltd. Announce Strategic Alliance
Companies announce that they have signed a strategic alliance agreement. In line with its strategic goal to develop innovative solutions for the fortification and supplement industry, Gadot is seeking new technologies to produce new health ingredients as well as to improve its current production processes.
- UTEK Corporation and Gadot Biochemical Industries, Ltd. Announce Strategic Alliance
Companies announce that they have signed a strategic alliance agreement. In line with its strategic goal to develop innovative solutions for the fortification and supplement industry, Gadot is seeking new technologies to produce new health ingredients as well as to improve its current production processes.
- UTEK Corporation and Gadot Biochemical Industries, Ltd. Announce Strategic Alliance
Companies announce that they have signed a strategic alliance agreement. In line with its strategic goal to develop innovative solutions for the fortification and supplement industry, Gadot is seeking new technologies to produce new health ingredients as well as to improve its current production processes.
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- New Company for “Change-The-World” Entrepreneurs™ Launches
- GMP Labs Expands Liquid Nutraceutical Capabilities
- What Parents Should Know About Kids and Supplements
- What Parents Should Know About Kids and Supplements
- Oats Beat Back Cholesterol
- Oats Beat Back Cholesterol
- Seniors: Pump Up for Strong Bones and Heart
- Seniors: Pump Up for Strong Bones and Heart
- Vitamin K2 as MK-7 (MenaQ7®) supplementation - essential for better bone health after organ transplantation
- Vitamin K2 as MK-7 (MenaQ7®) supplementation - essential for better bone health after organ transplantation
|
WEST CALDWELL, N.J., July 6, 2006 ‑ Nutratech, Inc. ‑ exclusive worldwide distributor of Advantra Z®, a proprietary bitter orange extract and the only patented thermogenic ingredient ‑ has filed a patent infringement lawsuit against Syntech International, a nutraceutical ingredient supplier based in Walnut, Calif.
The suit alleges that Syntech is selling and distributing bitter orange raw material in violation of Nutratech’s exclusive patents.
Advantra Z is protected by U.S. patent numbers 6,224,873; 6,316,499; 6,340,481; and 6,340,482 ‑ owned by Zhishin LLC and licensed exclusively to Nutratech ‑ for:
- Stimulating thermogenesis;
- Reducing weight;
- Increasing the percentage of lean muscle in relation to total body mass;
- Improving athletic performance; and
- Suppressing appetite.
Only Advantra Z is licensed under these patents to provide these benefits.
Nutratech, Inc., provides innovative, proprietary and patented nutraceutical ingredients to the dietary supplement, weight management, sports nutrition, beverage and food industries. The company is currently headquartered in West Caldwell, N.J. For more information on Nutratech and Advantra Z, visit the company’s web site at www.nutratechinc.com.
# # # |